Results

Total Results: 9,447 records

Showing results for "cancer".
Users also searched for: colon cancer screening

101. Chemo and Couns/2nd instal (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-hnLT26c2NHs6thK9yznPF
     July 01, 2002 - (70 cancers) Chemoprevention of Breast Cancer 39 Chemoprevention of Breast Cancer 40 studies … Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer … Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women’s Health Study: how many … nodes and estrogen receptor-positive tumors. … 1 Explode breast neoplasms 90,662 2 Limit 1 to (human and female) 70,714 3 Explode Tamoxifen 6,743

102. Liver Failure After Chemotherapy: Did We Forget Something? | PSNet
     psnet.ahrq.gov/web-mm/liver-failure-after-chemotherapy-did-we-forget-something
     May 01, 2019 - However, other causes of hepatitis must be excluded, including chemotherapy-induced hepatic injury, tumor … Rarely, hepatitis may be caused by tumor obstruction of the hepatic veins producing the Budd-Chiari syndrome … For other solid tumors, the rate of reactivation appears to be lower, ranging between 14% and 21%.( 11 … The more intensive chemotherapeutic regimens for hematological malignancy and breast cancer are particularly … Patients receiving rituximab or those treated for haematological malignancies and breast cancer appear

103. Archived: Final Evidence Summary: Skin Cancer: Screening, April 2001 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/skin-cancer-screening-2001
     April 01, 2001 - between 1994 and June 1999, using search terms for screening, physical examination, morbidity, and skin neoplasms … , biopsies, confirmed skin cancers, and stages and thickness of skin cancers. … cancer. 15 , 16 A large primary tumor >2 cm) is associated with an increased risk of metastasis. … from 1994 to June 1999, using search terms for screening, physical examination, morbidity, and skin neoplasms … The latter study 80 concluded that poor prognosis was due to rapidly growing tumors rather than delays

104. Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/cancer

105. Cancer-Anemia-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
     April 01, 2013 - patients, depending on the type of malignancy and treatment. … Transfusion is one option for treating anemia related to cancer and cancer treatment. … alloimmunization, overtransfusion, and immune modulation with theoretically possible adverse effects on tumor … strategies and non-ESA strategies to manage anemia in patients undergoing chemotherapy or radiation for malignancy … There was considerable variability among trials, such as trial duration, tumor types, cancer therapy

106. Disposition of Comments_Blood-Based Tests for Multiple Cancer Screening: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-disposition-comments.pdf
     May 14, 2025 - First, multi-cancer tests are designed to pick up many cancers, including cancers that are both dread … Rationale: The accuracy of a TOO (tumor of origin) offering is beyond the scope of KQ3, which is evaluating … is a function of known biologic features of tumor aggressiveness.20 • The draft report incorrectly … of such tumors may not alter the clinical trajectory. … draft report recognizes that some MCED technologies, such as GRAIL’s Galleri, recognize “shared tumor

107. Modeling Study: Colorectal Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-study18/colorectal-cancer-screening
     May 18, 2021 - incidence (excluding tumors that are not the target of colorectal cancer screening) among 20- to 44- … that are not the target of colorectal cancer screening (eg, carcinoid tumors). … or in addition) by faster progression to malignancy is unknown. … Contributions of adenocarcinoma and carcinoid tumors to early-onset colorectal cancer incidence rates … Prevalence of advanced, precancerous colorectal neoplasms in black and white populations: a systematic

108. Executive Summary_Blood-Based Tests for Multiple Cancer Screening: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-executive-summary.pdf
     May 01, 2025 - Multi- cancer early detection test sensitivity for cancers with and without current population- level … Neoplasia. Dec 2023;46:100941. doi:10.1016/j.neo.2023.100941 12. … Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA … TOTEM: a multi-cancer detection and localization approach using circulating tumor DNA methylation … Prospective validation study: a non-invasive circulating tumor DNA-based assay for simultaneous early

109. Bladder-Cancer-Non-Muscle-Invasive Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
     October 01, 2015 - These include the stage of the cancer, tumor grade (higher grade tumors are more likely to recur and … progress), whether the tumor is an initial tumor or a recurrence, number and size of tumors, and patient … tumors (SOE: high) … versus smaller tumors (SOE: low) … 1 cm or >2 cm) vs. smaller tumors.

110. Lung-Cancer-Nonsurgical-Therapies Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_executive.pdf
     June 01, 2013 - size, and tumor location … ablation, rather than tumor cell kill, allowing for little to no tumor cell repopulation between doses … Stereotactic ablative radiation therapy for primary lung tumors. … A systematic review of radiofrequency ablation for lung tumors. … Image-guided thermal ablation of lung malignancies. Radiology. 2011 Sep;260(3):633-55.

111. breast-cancer-imaging-protocol-131217 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_research-protocol.pdf
     December 17, 2013 - assess stage Comparator Comparison of multiple imaging modalities No comparator None Outcomes Tumor … Found 1 exp Diagnostic Imaging 1737346 2 exp Breast Neoplasms/dh, dt, pc, rt, su, th [Diet … Therapy, Drug Therapy, Prevention & Control, Radiotherapy, Surgery, Therapy] 101054 3 exp Neoplasm … exp survival analysis/ 190795 11 6 or 7 1163519 12 1 and 2 and 5 and 11 632 13 exp *Breast Neoplasms … characteristics Type(s) of imaging described Comparator Type(s) of comparators, if any Outcomes measured Tumor

112. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/DYFdTVu-UY3h7CWGdA7Zkh
     July 20, 2021 - MAIN OUTCOMES AND MEASURES Colorectal cancer incidence and mortality, test accuracy in detecting cancers … Among all cancers, it is third in incidence and cause of cancer death for both men and women.1 In addition … entails exposure to low-dose ionizing radiation (range, 0.8 to 5.3 mSv), which may increase the risk of malignancy … Interval cancers in a population-based screening program for colorectal cancer in Catalonia, Spain. … Extracolonic tumors of the gastrointestinal tract detected incidentally at screening CT colonography.

113. Screening for Cervical Cancer - Recommendations and Rationale (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/r7JMWkKKv2krN6cxKQUUfP
     January 01, 2010 - The majority of cervical cancers in the U.S. occur in women who have never been screened or who have … or DES exposure due to increased risk for vaginal neoplasms, but data on the yield of such screening … with HPV in older women are much less prevalent but carry a higher risk of progressing to cervical neoplasia … American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer. … Trends in cervical intra-epithelial neoplasia in Iceland through 1995: evaluation of targeted age groups

114. Cancer
     hcup-us.ahrq.gov/reports/factsandfigures/figures/2006/2006_5_3b.jsp
     January 01, 2006 - Cancer Discharge Prevalence for Cancer by Region, 2006 REGION DISCHARGES PER 100,000

115. Cancer
     hcup-us.ahrq.gov/reports/factsandfigures/figures/2006/2006_5_3c.jsp
     January 01, 2006 - Cancer Most Frequent Hospitalizations with a Principal Diagnosis of Cancer by Sex, 2006 … CANCER CCS DIAGNOSIS DISCHARGES IN THOUSANDS Male Female Cancer of bronchus, lung … 107 93 Cancer of colon 65 70 Cancer of breast 1 119 Cancer of prostate … 30 24 Cancer of kidney and renal pelvis 33 21 Cancer of uterus 0 44 Cancer … of bladder 32 11 Cancer of head and neck 30 12 Cancer of ovary 0 40 Cancer

116. Archived: Oral Cancer: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/oral-cancer-screening-1996
     January 01, 1996 - " includes a diverse group of tumors arising from the oral cavity. … Usually included are cancers of the lip, tongue, pharynx, and oral cavity. … Head and neck malignancies associated with HIV infection. … Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck … The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

117. Archived: Lung Cancer: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening-1996
     January 01, 1996 - physicians and radiologists. 5 Current radiographic technologies require greater than 20 doublings of tumor … persons found that those receiving chest x-rays every 6 months had a larger proportion of resectable tumors … the beginning and end of the trial. 14 Similar findings were reported in the Philadelphia Pulmonary Neoplasm … Although early-stage, resectable tumors were more common and 5-year survival significantly higher in … A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers

118. Icd-10 Dxccs Trends112817 (pdf file)
     hcup-us.ahrq.gov/datainnovations/ICD-10_DXCCS_Trends112817.pdf
     November 28, 2017 - 0.8 –2.9 43: Malignant neoplasm without specification of site 1,064 1,072 1,308 0.8 22.0 44: … 18,167 22,433 8.4 23.5 43: Malignant neoplasm without specification of site 4,728 4,931 3,062 4.3 … 45: Maintenance chemotherapy; radiotherapy 500 606 834 21.2 37.6 46: Benign neoplasm of uterus … 15,610 17,381 17,512 11.3 0.8 47: Other and unspecified benign neoplasm 20,852 23,784 22,214 14.1 … of pancreas 2,592 2,994 3,019 15.5 0.8 46: Benign neoplasm of uterus 15,610 17,381 17,512 11.3 0.8

119. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Xbtq4oDQwVo7KgmSjnnDbz
     November 01, 2021 - (n = 10 286), which had about 4 years of follow-up, 0.35% of examinations revealed an extracolonic malignancy … Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics … Association between early stage colon neoplasms and false-negative results from the fecal immunochemical … Accuracy of CT colonography for detection of large adenomas and cancers. … Extracolonic tumors of the gastrointestinal tract detected incidentally at screening CT colonography.

120. Addendum to Screening for Ovarian Cancer: Evidence Update for the USPSTF Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/QtuWfedsMmUb_sAuKWdsGg
     December 31, 2014 - via ultrasonography, serum tumor markers, or pelvic examination was not recommended (D recommendation … , serum tumor markers, or pelvic examination was not recommended (D recommendation). 3 In 2004, a … peritoneal cancer and ovarian tumors with uncertain behavior. … of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer … malignancy.